Wenjie Ma1,2, David A Drew1,2, Kyle Staller3,4. 1. Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States. 2. Division of Gastroenterology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, 02114-2696, Boston, MA, United States. 3. Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States. kstaller@mgh.harvard.edu. 4. Division of Gastroenterology, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, 02114-2696, Boston, MA, United States. kstaller@mgh.harvard.edu.
Abstract
PURPOSE OF REVIEW: Colonic motility disorders may be influenced by the gut microbiota, which plays a role in modulating sensory and motor function. However, existing data are inconsistent, possibly due to complex disease pathophysiology, fluctuation in symptoms, and difficulty characterizing high-resolution taxonomic composition and function of the gut microbiome. RECENT FINDINGS: Increasingly, human studies have reported associations between gut microbiome features and colonic motility disorders, such as irritable bowel syndrome and constipation. Several microbial metabolites have been identified as regulators of colonic motility in animal models. Modulation of the gut microbiota via dietary intervention, probiotics, and fecal microbiota transplant is a promising avenue for treatment for these diseases. An integration of longitudinal multi-omics data will facilitate further understanding of the causal effects of dysbiosis on disease. Further understanding of the microbiome-driven mechanisms underlying colonic motility disorders may be leveraged to develop personalized, microbiota-based approaches for disease prevention and treatment.
PURPOSE OF REVIEW: Colonic motility disorders may be influenced by the gut microbiota, which plays a role in modulating sensory and motor function. However, existing data are inconsistent, possibly due to complex disease pathophysiology, fluctuation in symptoms, and difficulty characterizing high-resolution taxonomic composition and function of the gut microbiome. RECENT FINDINGS: Increasingly, human studies have reported associations between gut microbiome features and colonic motility disorders, such as irritable bowel syndrome and constipation. Several microbial metabolites have been identified as regulators of colonic motility in animal models. Modulation of the gut microbiota via dietary intervention, probiotics, and fecal microbiota transplant is a promising avenue for treatment for these diseases. An integration of longitudinal multi-omics data will facilitate further understanding of the causal effects of dysbiosis on disease. Further understanding of the microbiome-driven mechanisms underlying colonic motility disorders may be leveraged to develop personalized, microbiota-based approaches for disease prevention and treatment.
Authors: Giovanni Barbara; Vincenzo Stanghellini; Giovanni Brandi; Cesare Cremon; Giovanni Di Nardo; Roberto De Giorgio; Roberto Corinaldesi Journal: Am J Gastroenterol Date: 2005-11 Impact factor: 10.864
Authors: Rapat Pittayanon; Jennifer T Lau; Yuhong Yuan; Grigorios I Leontiadis; Frances Tse; Michael Surette; Paul Moayyedi Journal: Gastroenterology Date: 2019-03-30 Impact factor: 22.682
Authors: Anne F Peery; Seth D Crockett; Caitlin C Murphy; Jennifer L Lund; Evan S Dellon; J Lucas Williams; Elizabeth T Jensen; Nicholas J Shaheen; Alfred S Barritt; Sarah R Lieber; Bharati Kochar; Edward L Barnes; Y Claire Fan; Virginia Pate; Joseph Galanko; Todd H Baron; Robert S Sandler Journal: Gastroenterology Date: 2018-10-10 Impact factor: 22.682
Authors: Anita Wichmann; Ava Allahyar; Thomas U Greiner; Hubert Plovier; Gunnel Östergren Lundén; Thomas Larsson; Daniel J Drucker; Nathalie M Delzenne; Patrice D Cani; Fredrik Bäckhed Journal: Cell Host Microbe Date: 2013-11-13 Impact factor: 21.023
Authors: Neelendu Dey; Vitas E Wagner; Laura V Blanton; Jiye Cheng; Luigi Fontana; Rashidul Haque; Tahmeed Ahmed; Jeffrey I Gordon Journal: Cell Date: 2015-09-24 Impact factor: 41.582
Authors: Jonna Jalanka-Tuovinen; Jarkko Salojärvi; Anne Salonen; Outi Immonen; Klara Garsed; Fiona M Kelly; Abed Zaitoun; Airi Palva; Robin C Spiller; Willem M de Vos Journal: Gut Date: 2013-12-05 Impact factor: 23.059
Authors: Muriel Derrien; Magnus Simrén; Julien Tap; Stine Störsrud; Boris Le Nevé; Aurélie Cotillard; Nicolas Pons; Joël Doré; Lena Öhman; Hans Törnblom Journal: Microbiome Date: 2021-03-26 Impact factor: 14.650